KRAS and neoplasm: Tumor suppressive effects were also highly correlated between KRAS G12C-driven tumors at 15 weeks post-tumor initiation and KRAS G12D-driven tumors at 9 weeks post-tumor initiation, when sgInert tumors were most similar in size (Fig. 2E; Spearman ρ = 0.90).